Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Selleck Chemical LLC LQZ-7I-E0108-25MG
SDP

Supplier:  Selleck Chemical LLC E010825MG

Encompass_Preferred

LQZ-7I is a novel selectively inhibitor of survivin dimerization with IC50s of 4 8 M and 3 1 M in prostate cancer cell lines PC-3 and C4-2 respectively LQZ-7I orally effectively inhibits xenograft tumor growth and induces survivin loss in tumors

Catalog No. 50-313-4708


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.